Skip to content

Clinical trials

Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 1 Country / region: Italy Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20151
20161
20183
20192
20211
20224
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated5
Recruiting3
Active, not recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche3
AbbVie2
Hutchmed2
A.O. Ospedale Papa Giovanni XXIII1
ADC Therapeutics S.A.1
Biomea Fusion Inc.1
Boston Medical Center1
Celgene1
Eli Lilly and Company1
Incyte Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell19
Lymphoma, Mantle-Cell9
Lymphoma, Non-Hodgkin8
Lymphoma, B-Cell, Marginal Zone7
Lymphoma, Follicular6
Lymphoma, Large B-Cell, Diffuse6
Waldenstrom Macroglobulinemia6
Lymphoma5
Recurrence5
Burkitt Lymphoma3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.